Trial Profile
A Randomized, Open-Label Study to Compare the Safety and Efficacy of Cyclosporine Dose Reduction With Cyclosporine Elimination in De Novo Renal Allograft Recipients Receiving Rapamune.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Mar 2011
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Sirolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Wyeth
- 23 Jul 2007 Status change
- 13 Dec 2005 New trial record.